Skip to content
PAVmed Inc. logo

PAVmed Inc. (PAVM) Q1 2024 Earnings

PAVM·Reported May 13, 2024·Before market open

PAVmed Inc. reported Q1 2024 revenue of $1.0M, missed analyst consensus of $1.1M by $40.0K. Diluted EPS came in at $-0.99, beat the $-1.67 consensus by $0.68.

Revenue
$1.0Mmissed by $40.0K
Consensus: $1.1M
Diluted EPS
$-0.99beat by $0.68
Consensus: $-1.67
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2024

Q1 2024 Earnings FAQ

Common questions about PAVmed Inc.'s Q1 2024 earnings report.

PAVmed Inc. (PAVM) reported Q1 2024 earnings on May 13, 2024 before market open.

PAVmed Inc. reported revenue of $1.0M and diluted EPS of $-0.99 for Q1 2024.

Revenue missed the consensus estimate of $1.1M by $40.0K. EPS beat the consensus estimate of $-1.67 by $0.68.

You can read the 10-Q periodic report (0001493152-24-018913) directly on SEC EDGAR. The filing index links above go to sec.gov.